Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Novel Formulation Strategies

Novel Formulation Strategies

Date: Thursday, 20 April 2017 - Friday, 21 April 2017
Location: Hyderabad

Guest of Honour

P B N Prasad

P B N Prasad
Deputy Drugs Controller (India), Central Drugs Standard Control Organization


"Novel Formulation Strategies" is a unique, pharma industry focused, event designed to discuss novel strategies for pharmaceutical product development. India is the largest manufacturer of generic medicines globally and therefore drug formulation strategies need to be updated and discussed in order to successfully develop novel formulations. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.

Academic Innovation Session: In this event a special session has been designated towards Academic Innovations. A large number of Pharmaceutical Scientists in Academic Institutions have been working on formulation development. In this session we aim to present selected Academic Formulation related Innovations which might have importance in industry but could otherwise go unnoticed by industry scientists. This session will be open to Regular Pre-Doctoral Research Scholars only. Each presentation will be for 5-10 minutes duration only and will be adjudged by the industry scientists. The presentation providing best innovation with direct application in pharmaceutical industry will be awarded Rs 11,000/- during the closing ceremony of the conference. Faculty (Registered Indian Delegate) presenting the innovation will not be eligible for the award but will be allowed to present.

The last date for submission of abstract for presentation in this session has been extended to March 31, 2017. The selected abstracts will be intimated latest by April 03, 2017. The selected presenters will be required to complete the registration process latest by April 07, 2017. Those not registering by the said date will loose the opportunity to present and the same will be offered to the next candidate. This event will be co-located with our 4th International conference “QbD in Pharma Development World Congress 2017” in Hyderabad, India. Registered delegates will have unrestricted access to all the co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Who Should Attend: Pharmaceutical Industry Scientists working in Formulation R & D or Product Development, Technology Transfer & Novel Drug Delivery Systems, Technical Experts in Pharmaceutical Manufacturing and Experts in Pharmaceutical Business Development

Venue and Dates: Hotel Radisson Hyderabad, HITEC City, Hyderabad, India on April 20-21, 2017

Sponsorship Options: Pharmaceutical Industry willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Agenda Topics

  • 505(b)2 – Innovations for US Market
  • Academic Innovation
  • Bio-waiver Strategies for BCS -1 / BCS 3 Oral Solids Dosage Forms
  • Bioequivalence Strategies for Oral Extended / Modified Release Formulations
  • Delivery of Protein Therapeutics & Biologicals
  • Formulation of Water Insoluble Drugs for IV Injections
  • Solubility & Oral Bioavailability Enhancement
  • Spray Systems for Nasal and Permeation Enhanced Topical Preparations
  • Strategies for Herbal Medicines
  • Taste Masking & Stability of Pediatric PFOS Dosage Forms
  • Temperature or Moisture Sensitive / Difficult to Formulate FDC Development Approaches

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Khalid Akhter Ansari, Team Lead, Novartis
Rakesh Bhasin, Head-Formulation, Biocon
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University
Rahul Chavan, Research Scholar, NIPER Hyderabad
Rambhau Devraj, Director Technical, Pulse Pharmaceuticals Pvt Ltd.
Ravi GS, Research Scholar, NGSMIPS Mangalore
Praveen Khullar, Senior Director, Sanofi Aventis Group
Avril Mathias, Research Scholar, Nitte University, Mangaluru
Amit Mirani, Pre-Doctoral Student, Institute of Chemical Technology
Gour Mukherji, Senior Pharmaceutical Consultant, Consultancy
Isha Naik, , Bombay College of Pharmacy
Rajiv Nayar, CEO, HTD Biosystems Inc.
Rohit Pawar, PhD Research Student, Institute of Chemical Technology
Rashmi Prabhu, PhD (Tech) Research Student, Institute of Chemical Technology
Arun Radhakrishnan, PG Scholar, JSS College of Pharmacy
Devendra Ridhurkar, Senior Scientist, Egis Pharmaceuticals
Muhammad Sameer Safadi, Senior Director, Teva Pharmaceutical Industries, Ltd.
Hemali Savla, Predoctoral Research Fellow, Bombay College of Pharmacy
Manfred Schuster, CEO, ReMute-Bio GmbH
Pankaj Kumar Sharma, PhD Research Scholar , DIPSAR
Shamkant Shimpi, Vice President, Centaur Pharmaceutical Limited
Satish Singh, Head, Lonza Inc
Jan Vertommen, Senior Director, Capsugel

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2017-04-20 00:00:002017-04-21 00:00:00Europe/LondonNovel Formulation StrategiesNovel Formulation Strategies in